All it takes is 1-2 big sellers to send this stock up or down. Someone really wants out. It's useless to assume whether this is responsive to something known about the company.
I agree, some PR would be welcomed: uplisting, new drug, affirming guidance again, something.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.